- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02818179
Monitoring HDR Brachytherapy for Cervical Cancer by Optic and Thermal Imaging
October 13, 2016 updated by: Dr. Tatiana Rabin MD, Sheba Medical Center
This research aims to investigate the correlation between tumor temperature difference and biological factors, such as size, metabolism, treatment response, and tumor aggressiveness.
In addition, normal tissue response to radiation therapy in treated organ will be evaluated.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- signed informed consent
- biopsy proven cervical cancer which will undergo definitive radiation
Exclusion Criteria:
- not eligible to sign informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Patients undergoing radiation
In this study, patients undergoing radiation treatment will undergo thermography imaging during radiation treatment course.
Patients will be evaluated with thermography imaging every week during the brachytherapy treatment for 5 procedures
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change in Infra-Red radiation emitted at wavelengths 0.8-1nm
Time Frame: Baseline and 4 weeks
|
Measurement of IR
|
Baseline and 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluating of efficacy of the radiation
Time Frame: 3 months after the treatment
|
The thermal and the optic imaging will be taken and analyzed in order to evaluate the changing in the temperature of the cervix comparing to the baseline as the indication of the response to the radiotherapy
|
3 months after the treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2016
Primary Completion (Anticipated)
July 1, 2017
Study Completion (Anticipated)
July 1, 2017
Study Registration Dates
First Submitted
June 16, 2016
First Submitted That Met QC Criteria
June 28, 2016
First Posted (Estimate)
June 29, 2016
Study Record Updates
Last Update Posted (Estimate)
October 14, 2016
Last Update Submitted That Met QC Criteria
October 13, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHEBA-16-3171-RT-CTIL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on MALIGNANCY
-
Eben RosenthalVanderbilt University Medical Center; Vanderbilt-Ingram Cancer CenterWithdrawnCancer | Solid Tumor Cancer | Malignancy | Solid Tumor MalignancyUnited States
-
Memorial Sloan Kettering Cancer CenterCivaTech OncologyCompletedAbdominal Malignancy | Pelvic MalignancyUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingMalignancyUnited States
-
University of SaskatchewanCompleted
-
McGill University Health Centre/Research Institute...Unknown
-
BeOne MedicinesNot yet recruiting
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
CephalonCompleted
-
University of RochesterRecruitingMyeloid MalignancyUnited States
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
Clinical Trials on THERMOGRAPHY IMAGING
-
Sheba Medical CenterTel Aviv UniversityUnknown
-
RWTH Aachen UniversityCompleted
-
Sunnybrook Health Sciences CentreCompletedRadiodermatitis | Radiotherapy Side EffectCanada
-
Poissy-Saint Germain HospitalUnknown
-
ThermoMind Ltd.M.D. Anderson Cancer Center; Technion, Israel Institute of Technology; Sheba... and other collaboratorsRecruiting
-
National Heart Centre SingaporeNanyang Technological UniversityCompletedCarotid Artery DiseasesSingapore
-
Cairo UniversityRecruitingErector Spinae Plane Block | Paediatric | Thermography | Prediction | Infrared | Unilateral Inguinal Hernia SurgeryEgypt
-
University Hospital, Basel, SwitzerlandCompletedGlaucomaSwitzerland
-
Xiaomei ShaoFirst People's Hospital of Hangzhou; Zhejiang Provincial Tongde HospitalCompleted